Case 17-2007: A 25-year-old woman with relapsing fevers and recent onset of dyspnea

New England Journal of Medicine

Volumn 356, Issue 22, 2007, Pages 2313-

  Stowell, Christopher P ^a,b   Gelfand, Jeffrey A ^a,b   Shepard, Jo Anne O ^a,b   Kratz, Alexander ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CEFTRIAXONE; CLINDAMYCIN; DOXYCYCLINE; LAMOTRIGINE; LEVOTHYROXINE; QUININE;

ACUTE RESPIRATORY FAILURE; ADULT; ANAMNESIS; ARTICLE; BABESIA MICROTI; BABESIOSIS; BLOOD SMEAR; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; DYSPNEA; EXCHANGE BLOOD TRANSFUSION; FEMALE; HEARING IMPAIRMENT; HEREDITARY SPHEROCYTOSIS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOTHYROIDISM; LABORATORY TEST; MUFFLED HEARING; OXYGEN SATURATION; OXYGEN THERAPY; PRIORITY JOURNAL; SEIZURE; TEMPERATURE; ADULT RESPIRATORY DISTRESS SYNDROME; BLOOD EXAMINATION; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; ERYTHROCYTE; FEVER; LUNG; PATHOLOGY; RADIOGRAPHY; RECURRENT DISEASE; SPLENECTOMY;

ADULT; BABESIOSIS; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; ERYTHROCYTES; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; FEVER; HEMATOLOGIC TESTS; HUMANS; LUNG; RECURRENCE; RESPIRATORY DISTRESS SYNDROME, ADULT; SPHEROCYTOSIS, HEREDITARY; SPLENECTOMY;

EID: 34249795797     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc079011     Document Type: Article

References (26)

1. Kutter D, Coulon N, Stirn F, Thoma M, Janecki J. Demonstration and quantification of "hyperchromic" erythrocytes by haematological analysers: application to screening for hereditary and acquired spherocytosis. Clin Lab 2002;48:163-70.
2. Jacoby GA, Hunt JV, Kosinski KS, et al. Treatment of transfusion- transmitted babesiosis by exchange transfusion. N Engl J Med 1980;303:1098-100.
3. Krause PJ, Spielman A, Telford SR III, et al. Persistent parasitemia after acute babesiosis. N Engl J Med 1998;339:160-5.
4. Gelfand JA, Callahan MV. Babesiosis. Curr Clin Top Infect Dis 1998;18:201-16.
5. Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001;32:1117-25.
6. White DJ, Talarico J, Chang HG, Birkhead GS, Heimberger T, Morse DL. Human babesiosis in New York State: review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998;158:2149-54.
7. Raoult D, Soulayrol L, Toga E, Dumon H, Casanova P. Babesiosis, pentamidine, and cotrimoxazole. Ann Intern Med 1987;107:944.
8. Falagas ME, Klempner MS. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis 1996;22:809-12.
9. Weiss LM, Wittner M, Tanowitz HB. The treatment of babesiosis. N Engl J Med 2001;344:773.
10. Hughes WT, Oz HS. Successful prevention and treatment of babesiosis with atovaquone. J Infect Dis 1995;172:1042-6.
11. Corpelet C, Vacher P, Coudore F, Laurichesse H, Conort N, Souweine B. Role of quinine in life-threatening Babesia divergens infection successfully treated with clindamycin. Eur J Clin Microbiol Infect Dis 2005;24:74-5.
12. Dorman SE, Cannon ME, Telford SR III, Frank KM, Churchill WH. Fulminant babesiosis treated with clindamycin, quinine, and whole-blood exchange transfusion. Transfusion 2000;40:375-80.
13. Rosner F, Zarrabi M, Benach JL, Habicht GS. Babesiosis in splenectomized adults: review of 22 cases. Am J Med 1984;76:696-701.
14. Boustani MR, Lepore JT, Gelfand JA, Lazarus DS. Acute respiratory failure in patients treated for babesiosis. Am J Respir Crit Care Med 1994;149:1689-91.
15. Setty S, Khalil Z, Schori P, Azar M, Ferrieri P. Babesiosis: two atypical cases from Minnesota and a review. Am J Clin Pathol 2003;120:554-9.
16. Shaio MF, Lin PR. A case study of cytokine profiles in acute human babesiosis. Am J Trop Med Hyg 1998;58:335-7.
17. Dzikowski R, Deitsch K. Antigenic variation by protozoan parasites: insights from Babesia bovis. Mol Microbiol 2006;59:364-6.
18. O'Connor RM, Allred DR. Selection of Babesia bovis-infected erythrocytes for adhesion to endothelial cells coselects for altered variant erythrocyte surface antigen isoforms. J Immunol 2000;164:2037-45.
19. Powell VI, Grima K. Exchange transfusion for malaria and Babesia infection. Transfus Med Rev 2002;16:239-50.
20. Pantanowitz L, Telford SR III, Cannon ME. The impact of babesiosis on transfusion medicine. Transfus Med Rev 2002;16:131-2.
21. Case Records of the Massachusetts General Hospital (Case 32-2006). N Engl J Med 2006;355:1715-22.
22. Chen Q, Schlichtherle M, Wahlgren M. Molecular aspects of severe malaria. Clin Microbiol Rev 2000;13:439-50.
23. Hemmer RM, Ferrick DA, Conrad PA. Up-regulation of tumor necrosis factoralpha and interferon-gamma expression in the spleen and lungs of mice infected with the human Babesia isolate WA1. Parsitol Res 2000;86:121-8.
24. O'Connor RM, Long JA, Allred DR. Cytoadherence of Babesia bovis-infected erythrocytes to bovine brain capillary endothelial cells provides an in vitro model for sequestration. Infect Immun 1999;67:3921-8.
25. Leiby DA, Chung AP, Cable RG, et al. Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors. Transfusion 2002;42:1585-91.
26. Leiby DA, Chung A, Gill JE, et al. Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti. Transfusion 2005;45:1804-10.